KOCAA
ONC

Knights of Columbus Asset Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-447
Closed -$80.4K – 388
2023
Q3 		$80.4K Buy
447
+76
+20% +$15K 0.01% 351
2023
Q2 		$66.1K Buy
371
+14
+4% +$3.22K 0.01% 359
2023
Q1 		$76.9K Buy
+357
New +$85.6K 0.01% 336

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Knights of Columbus Asset Advisors's ONC Position: Q4 2023 in Review

Knights of Columbus Asset Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 447 shares — an estimated $80.4K sold.

Knights of Columbus Asset Advisors first reported a position in ONC in Q1 2023 and held it in 3 quarters. The position peaked at $80.4K in Q3 2023. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Knights of Columbus Asset Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 447 BeOne Medicines Ltd shares in Q4 2023, an estimated $80.4K.
  • Knights of Columbus Asset Advisors first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 3 quarters.
  • Knights of Columbus Asset Advisors's BeOne Medicines Ltd position peaked at $80.4K in Q3 2023.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Knights of Columbus Asset Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.